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Summary Leptin-deficient ob/ob mice are a murine model for obesity, insulin resistance, and
diabetes. Here we report that non-lethal abdominal irradiation (a single fraction of 850 cGy)
to ob/ob mice retarded rapid gain of body weight, leading to amelioration of obesity without
marked changes in food intake. This effect was observed only in ob/ob mice and not in lean
controls. Reduction of body weight was accompanied by decreased adipose tissue weight
without any marked change in the size of adipocytes, indicating prevention of hyperplasia
rather than hypertrophy. Gene expression of the radiation-inducible cdk-inhibitor, p21, and
the adipocytokines, tumor necrosis factor α and interleukin-1β, were induced as expected; but
genes involved in adipogenesis such as peroxisome proliferator-activated receptor γ and
adipsin were not affected in the irradiated adipose tissue. Inversely, hepatic lipid content was
elevated with concomitant increases in the expression of lipogenic enzymes such as fatty acid
synthase (FAS), and sterol regulatory element-binding protein 1c. Despite the decreased
adiposity, there was no improvement in hyperglycemia and hyperinsulinemia after the
irradiation. In conclusion, abdominal irradiation to ob/ob mice affected the progression of obe-
sity and altered the energy metabolism between organs through a novel mechanism,
implicating a new approach or factor for understanding and treatment of obesity.
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Introduction
Obesity occurs when energy intake exceeds energy ex-
penditure. Leptin is an adipocyte-derived hormone that
plays a central role in the regulation of energy metabolism in
the body [1, 2]. Leptin-deficient ob/ob mice are a model
for obesity, insulin resistance, diabetes, and nonalcoholic
steatohepatitis [3]. In ob/ob mice, the absence of the leptin
signal in the hypothalamus causes obesity due to increase in
food intake and decrease in energy expenditure. This is
accompanied by hypertrophic and hyperplastic changes of
adipocytes within white adipose tissue, and lipid accumulation
in the liver. The increased adiposity is associated with insulin
resistance with marked hyperinsulinemia, ultimately resulting
in diabetes. Recently, pro-inflammatory proteins secreted
from adipose tissue, often referred as adipokines, such as
tumor necrosis factor α (TNFα) have been shown to be
involved in the development of metabolic syndrome and
cardiovascular risks [4, 5]. In addition, infiltration of macro-
phages into the fat and their interaction with the adipocytes
is involved in the adipose tissue-initiated inflammation and
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insulin resistance [6, 7].
Seeking for a new therapeutic approach to obesity, we
have been exploring the potential impact of bone marrow-
derived cells containing mesenchymal stem cells on energy
metabolism in the whole body. Bone marrow transplantation
caused consistent amelioration of obesity in ob/ob mice, but
no change in the body weight of normal mice. Intriguingly,
it was found that the irradiation to the body given as a
pretreatment for the transplantation was responsible for the
inhibition of body weight gain in ob/ob mice (unpublished
data, Kobayashi K and Shimano H). In the current study, we
investigated the specific effects of radiation on body weight
and adiposity in ob/ob and wild-type mice.
Materials and Methods
Materials
All reagents were obtained from Sigma Chemicals.
Enhanced chemiluminescence western blot detection kit and
redivue [α-32P] dCTP were purchased from Amersham
Pharmacia. Standard molecular methods were used.
Animals
The animal studies were approved by the Animal Care
Committee of the University of Tsukuba. ob/ob mice (B6.V-
Lepob homo, background strain: C57BL/6J) were obtained
from the Jackson Laboratory, MA, and bred in the colony.
Control C57BL/6 mice and littermates of B6.V-Lep+/+ were
purchased from Charles River Laboratories. The mice were
housed in colony cages and maintained on a 12-h light/12-h
dark cycle and given free access to water and standard chow
diet (MF; Oriental Yeast, Tokyo, Japan).
Abdominal irradiation
A single fraction of 850cGy was delivered to the abdominal
region of ob/ob and control mice using a gamma cell. The
head and lower limbs were protected from radiation using
shield lead blocks. This protocol was established as follows.
Based on our initial finding that total body irradiation used
for bone marrow transplantation causes suppression of weight
gain in ob/ob mice, we investigated the dose-dependency
and body-subfractional differences in this radiation effect. It
was found that a single fraction of 850 cGy to the abdomen
of  db/db mice was non-lethal and did not require bone
marrow transplantation for survival, but had an obesity-
inhibiting potential comparable to the total body irradiation
(850 cGy) with the bone marrow transplantation at 18 weeks
of age.
Measurement of the biochemical data
Blood was collected from the retro-orbital venous plexus
in mice fed ad libitum. The concentrations of plasma glucose,
insulin, triglycerides (TG), cholesterol, and nonesterified
fatty acids (NEFA) were measured using the following kits
and a multilabel counter, ARVO SX 1420 (Perkin Elmer,
MA).
Glucose: Glucose CII-test WAKO; Wako Pure Chemical
Industries, Japan.
Insulin: Mouse Insulin ELISA (TMB) Kit; Shibayagi Co.
Ltd., Japan.
Total cholesterol: Cholesterol C-test WAKO; Wako Pure
Chemical Industries, Japan.
TG: Triglyceride G-test WAKO; Wako Pure Chemical
Industries, Japan.
NEFA: NEFA C-test WAKO; Wako Pure Chemical Industries,
Japan.
Measurement of liver TG and cholesterol was as previously
described [8].
Measurement of food intake
Food intake was measured for 5 days after the mice had
been adapted to individual housing for 1 week.
Measurement of body composition
Fat mass and lean tissue mass were determined using
dual-energy X-ray absorptiometry (DEXA) (PIXImus;
Lunar Corporation, Madison, WI) as previously described
[9].
Northern blot analysis
Total RNA was extracted from the liver (10 µg) and
adipose tissue (5 µg) of the mice and subjected to Northern
blot analysis as previously described [8]. cDNA probes used
were as previously described [10, 11].
Statistical evaluation
Two-tailed Student’s t test was used for statistical evaluation.
Results
Inhibitory effects of abdominal irradiation on body weight
gain of ob/ob mice
Both male and female ob/ob mice gain body weight and
adiposity more markedly and rapidly than their wild-type
lean littermates (Fig. 1). This leptin deficiency-mediated
acceleration of body weight gain was markedly retarded by
irradiation (a single fraction of 850 cGy) in ob/ob mice of
both sexes at 9 weeks of age (Fig. 1A and B). The inhibition
of body weight gain became obvious approximately 8–10
weeks after the irradiation, suggesting that it was not due to
acute radiation side-effects. Reduction of body weight gain
by the irradiation was more prominent in female ob/ob mice
than in males. In contrast, wild-type C57BL6 mice of both
sexes did not show any significant percentage body weight
change after a single irradiation with the same dose
throughout the observation period of up to 20 weeksAmelioration of Obesity by Irradiation
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(Fig. 1C and D). The radiation effect was also tested at a
later age (15 weeks), and a similar suppression of body
weight gain was found only in ob/ob mice (data not shown).
Food intake was measured in both wild-type and ob/ob mice
at 7 and 9 weeks after the radiation (Fig. 2). Unlike other
manipulations to reduce the body weight of obese mice,
abdominal irradiation did not significantly change their food
intake. The calculated feeding efficiency showed a decreasing
trend (data not shown). These data indicate that the
suppressed body weight gain could not be explained by
reduced ingestion of energy due to chronic side-effects on
the gastrointestinal system. Analysis of total body adipose
tissue by DEXA revealed that the loss of body weight
was attributed to a decrease in fat weight, whereas lean
mass weight was not changed (Fig. 3). The gross appearance
and anatomical inspection of the animals suggested that the
decreased adiposity was proportional throughout the body
and not restricted to the irradiated abdominal region (data
not shown).
Effects of irradiation on metabolic parameters
Plasma metabolic parameters were measured at several
time points during the growth curve. Plasma glucose, TG,
and cholesterol levels were higher in ob/ob diabetic mice
compared with wild-type mice; however, abdominal irradiation
had no significant effects on these parameters (Table 1).
Plasma insulin levels were markedly elevated in ob/ob mice
because of severe insulin resistance. There was a decreasing
trend in plasma insulin level in irradiated male ob/ob mice
compared with the non-irradiated control group. Thus,
improvement of insulin resistance abdominal irradiation as
estimated by plasma parameters was less prominent than
expected from the loss of body weight.
Effects of irradiation on liver, adipose tissue, and gene
expression
Three or 6 months after the irradiation, the animals were
killed in a 12-h fasted state. There was a slight decrease in the
weights of abdominal adipose tissues such as the epididymal
fat pads and parametric fat pads in the irradiated ob/ob mice
compared with the non-radiated controls (Table 2). Conversely,
Fig. 1.  Time-dependent changes in body weights of male (A and C) and female (B and D) ob/ob (OB, A and B) and wild type (C and
D) mice (WT) after abdominal irradiation (Abd-Rad). Data presents mean ± SEM (g or %) (n = 7–9). *p<0.05, **p<0.01
compared with the respective non-irradiated controls (Non-Rad). Note that the data from WT mice are shown as ratio vs initial
body weight at the time of irradiation.S. Okada et al.
J. Clin. Biochem. Nutr.
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there was a slight trend of enlargement of the liver on
irradiation. Histological examination demonstrated that there
were no significant differences in the size or appearance of
adipocytes in adipose tissue between the irradiated and
non-irradiated groups (Fig. 4A). Infiltration of macrophages
is known to be observed in the increased adipose tissue
of obese mice including ob/ob, and these macrophages
contribute to pro-inflammatory responses and to insulin
resistance [6,  12]. The infiltration of macrophages was
slightly enhanced by the irradiation (Fig. 4A). Irradiation
did not cause significant histological changes in the small
intestine of wild-type and ob/ob mice (Fig. 4B). Hepatic lipid
accumulation, as an indication of hepatosteatosis, increased
slightly in the irradiated group, as visualized by an increase
in both number and size of lipid droplets (Fig. 5). There was
a consistent and significant increase in the hepatic TG
content, but not in the cholesterol content by irradiation
(Table 2). Northern blot analysis showed that hepatic
expression of sterol regulatory element-binding protein-1c
(SREBP-1c) and its lipogenic gene targets such as fatty acid
synthase [13,  14], as well as peroxisome proliferator-
activated receptor γ (PPARγ) increased, suggesting that
the already activated hepatic lipogenesis in ob/ob mice
was further enhanced by abdominal irradiation (Fig. 6).
Expression of PPARα, a well-known regulator of lipid
degradation, was not changed. In adipose tissues, expression
of PPARγ and adipsin, markers of adipocyte differentiation
were not changed by irradiation. Radiation and other cellular
stresses are known to arrest cell growth at G1 by activating
p21, a cyclin-dependent kinase inhibitor and a known p53
target [15, 16]. Recently, we reported activation of p21 in
both liver and adipose tissues of ob/ob mice [17,  18].
Expression of p21 was further induced in both liver and
adipose tissue by abdominal irradiation. TNFα along with
interleukin-1β (IL-1β) is believed to be involved in the
adipokine hypothesis [4] and is induced by irradiation.
Discussion
Our current study clearly demonstrates that abdominal
irradiation retards the body weight gain of ob/ob mice and
ameliorates obesity. We conclude that this protection is not
simply due to acute radiation injury to the gastrointestinal
tract. The reasons are as follows: 1) there was no significant
change in food intake nor diarrhea indicating malabsorption
(data not shown); 2) body weight loss became prominent 8
weeks after irradiation; and 3) body weight loss by abdominal
irradiation was observed only in ob/ob mice and not in wild-
type mice.
There are numerous possible mechanisms that could
account for this protection from weight gain. It is possible
that chronic gastrointestinal injury could be involved; how-
ever, no gross histological changes were detected in the
intestine of irradiated mice (Fig. 4B). In addition, induction
or suppression of hormonal factors from irradiated abdominal
organs could cause body weight loss. First, cortisol deficiency
from adrenal insufficiency is a possible mechanism by
which weight gain in ob/ob mice could be suppressed, as
adrenalectomy has been reported to ameliorate the obesity
phenotypes of ob/ob mice [19]. However, reversal of pre-
obesity by removal of the adrenal glands was associated
with a decrease in food intake and plasma insulin level,
neither of which was observed in the abdominally irradiated
ob/ob mice [20–23]. Second, TNFα could be involved in
the current findings because it has a cachectic action by
activation of lipolysis. Expression of TNFα is activated in
ob/ob adipose tissue, as previously reported, and is further
enhanced after irradiation. However, the absence of
cachectic effects in irradiated lean normal mice makes these
two factors less likely to be the main cause. Despite the
amelioration of obesity, irradiated ob/ob mice showed
Fig. 2.  Food intake of irradiated (Abd-Rad) and non-irradiated
(Non-Rad) ob/ob mice after irradiation. Food intake was
evaluated by measuring chow, 7 and 9 weeks after the
irradiation (n = 6–8).Amelioration of Obesity by Irradiation
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sustained hyperinsulinemia and hyperglycemia. Food intake
was not changed, and thus energy balance was not improved.
However, activation of TNFα could contribute to peripheral
insulin resistance [4]. Activation of adipokines such as TNFα
and IL-1β could explain the sustained insulin resistance
despite the marked amelioration of obesity.
DEXA revealed that weight gain was suppressed through
decreased adiposity, indicating an effect of abdominal irradi-
ation on the progress of adipose tissue to obesity in ob/ob
mice. Obesity generally consists of both hypertrophy and
hyperplasia of adipocytes. Decreased adiposity with no
change in the size of adipocytes indicated that abdominal
Fig. 3.  Lean mass volume and fat mass volume of irradiated ob/ob mice (Abd-Rad) assessed by DEXA. Values are expressed as
mean ± SEM (n = 6–12). **p<0.01 compared with non-irradiated controls (Non-Rad).
Table 1. Serum parameters of irradiated (Abd-Rad) and non-irradiated (Non-Rad) male and female ob/ob and wild type (WT) mice fed
ad libitum
WT male WT female ob/ob male ob/ob female
Non-Rad Abd-Rad Non-Rad Abd-Rad Non-Rad Abd-Rad Non-Rad Abd-Rad
n 1 31 4 1 51 5 2 3 1 8 2 9 3 0
insulin 
(pg/ml)
929 ± 146 1510 ± 192 299 ± 82.8 834 ± 379 62300 ± 15400 47800 ± 18200 40000 ± 11600 40900 ± 5140
glucose 
(mg/dl)
265 ± 15.6 270 ± 18.1 204 ± 9.9 206 ± 11.8 225 ± 14.8 227 ± 15.4 238 ± 12.2 250 ± 10.3
T. Chol 
(mg/dl)
113 ± 4.4 109 ± 4.1 93.1± 6.6 87.7± 4.2 239 ± 13.1 230 ± 12.1 190 ± 10.1 205 ± 8.6
TG 
(mg/dl)
177 ± 16.0 165 ± 15.1 127 ± 29.4 104 ± 7.9 161 ± 8.9 175 ± 15.2 119 ± 5.7 119 ± 5.4
NEFA 
(mEq/l)
0.69 ± 0.04 0.68 ± 0.05 0.69 ± 0.02 0.70 ± 0.11 0.58 ± 0.03 0.69 ± 0.04 0.64 ± 0.03 0.73 ± 0.07
T. Chol: total cholesterol, TG: triglycerides, and NEFA: non-esterified fatty acids. Values are expressed as mean ± SEM.S. Okada et al.
J. Clin. Biochem. Nutr.
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irradiation inhibits hyperplasia rather than hypertrophy of
ob/ob adipocytes. p21, a potent cdk inhibitor, was highly
induced in ob/ob adipocytes [17]. It is also reported to be
induced at the time of clonal expansion in the differentiation of
3T3-L1 fibroblasts to adipocytes [24]. These data implicate
the potential involvement of p21 in adipogenesis and
obesity. Enhanced induction of p21 in the adipose tissue
supports the concept that impairment of cell growth was
involved in the decreased adiposity of irradiated ob/ob mice.
It is known that hepatocytes of ob/ob mice are hyper-
plastic and prone to hepatocellular carcinoma [25]. By
extending the observation period to more than 40 weeks
after the irradiation, hepatic tumors were found with a slightly
higher incidence in ob/ob mice than in wild-type mice. Thus,
Table 2. Organ and tissue weight of irradiated (Abd-Rad) and non-irrdiated (Non-Rad) male and female ob/ob and wild type (WT) mice
3 months and 6 months after the irradiation
WT male WT female ob/ob Male ob/ob Female
Non-Rad Abd-Rad Non-Rad Abd-Rad Non-Rad Abd-Rad Non-Rad Abd-Rad
3 months after the irradiation
n9 9 5 4 6 9 7 7
Body weight (g) 28.7 ± 1.26 27.3 ± 0.79 20.6 ± 0.40 21.2 ± 1.25 58.6 ± 1.80 53.2 ± 1.47** 61.0 ± 1.36 53.8 ± 1.24**
Liver weight (g) 1.13 ± 0.05 1.12 ± 0.04 0.82 ± 0.06 1.01 ± 0.10 3.66 ± 0.39 3.96 ± 0.31 3.32 ± 0.23 3.30 ± 0.21
Paragonadal 
WAT (g)
0.66 ± 0.13 0.54 ± 0.05 0.23 ± 0.04 0.30 ± 0.09 2.80 ± 0.58 2.11 ± 0.27 3.52 ± 0.34 3.44 ± 0.25
6 months after the irradiation
n 1 5 1 61 3 1 51 4 1 32 0 2 1
Body weight (g) 33.7 ± 0.75 31.2 ± 0.93 25.0 ± 0.56 24.6 ± 0.63 69.5 ± 2.12 57.3 ± 1.56** 68.4 ± 1.68 57.4 ± 1.28**
Liver weight (g) 1.26 ± 0.03 1.17 ± 0.04 1.00 ± 0.03 1.03 ± 0.03 3.72 ± 0.15 3.99 ± 0.19 3.40 ± 0.14 3.49 ± 0.11
Paragonadal 
WAT (g)
1.11 ± 0.14 0.95 ± 0.11 0.49 ± 0.07 0.51 ± 0.06 1.73 ± 0.16 1.45 ± 0.16** 2.83 ± 0.10 2.66 ± 0.12
Liver TG (mg/g) 79.9 ± 11.9 57.5 ± 6.0 77.8 ± 11.7 68.5 ± 21.1 167 ± 13.5 214 ± 3.9* 170 ± 18.3 232 ± 12.9*
Values are expressed as mean ± SEM.
Asterisks indicate significant differences between non-radiated mice and abdominal radiated mice (**p<0.01, *p<0.05).
Fig. 4.  Histological examination of adipose tissues (parametric
fats) (A) and small intestine (jejunum) (B) from female
ob/ob and wild type mice 12 weeks after abdominal
irradiation (magnification 40 ×).
Fig. 5.  Histological examination of livers from female ob/ob
and wild type mice 12 weeks after abdominal irradiation
(magnification 100 ×).Amelioration of Obesity by Irradiation
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it is possible that the cachectic action of radiation could
predispose ob/ob mice to hepatic tumors [26].
Amelioration of obesity without decreased food intake led
us to speculate on the fate of dietary energy in ob/ob mice
after abdominal irradiation, which is currently unknown. In
a reciprocal response to decreased adiposity, hepatic lipid
content increased with a slight increase in lipogenesis by
SREBP-1c. Abdominal irradiation could cause a shift of
energy from adipose tissue to the liver as the secondary
reservoir for excess energy. In addition to radiation injury,
abdominal irradiation seems to contribute to insulin resistance
by pro-inflammatory activation. Thus, abdominal irradiation
itself is unlikely to be a future therapeutic tool against
obesity. However, further studies on the precise mechanism
by which irradiation works against weight gain may reveal a
new factor or process that could help in the understanding of
adipose tissue expansion.
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